Business ❯Pharmaceutical Industry
Bristol Myers Squibb Foreign Investment Johnson & Johnson J.P. Morgan Healthcare Conference Financial Outlook
The acquisition aims to boost J&J's oncology portfolio with Ambrx's promising antibody-drug conjugates technology.
